Critical role of the NKG2D receptor for NK cell-mediated control and immune escape of B-cell lymphoma

CD40-independent natural killer-cell help promotes dendritic cell vaccine-induced T-cell immunity against endogenous B-cell lymphoma

(2014) Nadine Hömberg et al.   INTERNATIONAL JOURNAL OF CANCER

IL-2–dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells

(2013) Georg Gasteiger et al.   JOURNAL OF EXPERIMENTAL MEDICINE

T-helper-1-cell cytokines drive cancer into senescence

(2013) Heidi Braumüller et al.   NATURE

Generation of Soluble NKG2D Ligands: Proteolytic Cleavage, Exosome Secretion and Functional Implications

(2013) G. Chitadze et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Melanoma Cells Inhibit Natural Killer Cell Function by Modulating the Expression of Activating Receptors and Cytolytic Activity

(2012) G. Pietra et al.   CANCER RESEARCH

Recruitment of Natural Killer Cells in Advanced Stages of Endogenously Arising B-cell Lymphoma

(2012) Margarethe Przewoznik et al.   JOURNAL OF IMMUNOTHERAPY

Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma

(2011) S. Platonova et al.   CANCER RESEARCH

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity

(2011) Emilie Mamessier et al.   JOURNAL OF CLINICAL INVESTIGATION

Cancer Immunoediting of the NK Group 2D Ligand H60a

(2011) T. O'Sullivan et al.   JOURNAL OF IMMUNOLOGY

A gene expression signature identifies two prognostic subgroups of basal breast cancer

(2010) Renaud Sabatier et al.   BREAST CANCER RESEARCH AND TREATMENT

EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion

(2009) A. Ziegler et al.   BLOOD

DC therapy induces long-term NK reactivity to tumors via host DC

(2009) Kanako Shimizu et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Requirements for control of B-cell lymphoma by NK cells

(2009) Christoph D. Brenner et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Altered NK Cell Development and Enhanced NK Cell-Mediated Resistance to Mouse Cytomegalovirus in NKG2D-Deficient Mice

(2009) Biljana Zafirova et al.   IMMUNITY

Direct and Natural Killer Cell-Mediated Antitumor Effects of Low-Dose Bortezomib in Hepatocellular Carcinoma

(2008) S. Armeanu et al.   CLINICAL CANCER RESEARCH

NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous Malignancy

(2008) Nadia Guerra et al.   IMMUNITY

Interferon-γ down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells

(2008) Nicole Schwinn et al.   INTERNATIONAL JOURNAL OF CANCER

Functions of natural killer cells

(2008) Eric Vivier et al.   NATURE IMMUNOLOGY

Stromal gene expression predicts clinical outcome in breast cancer

(2008) Greg Finak et al.   NATURE MEDICINE